Boulogne-Billancourt, France

Henri Bermudez

This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, Synthelabo. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Henri Bermudez: Innovator in Nutritional Supplements

Introduction

Henri Bermudez is a notable inventor based in Boulogne-Billancourt, France. He has made significant contributions to the field of nutritional supplements, particularly in the treatment of uremia. His innovative approach has garnered attention in both academic and commercial circles.

Latest Patents

Henri Bermudez holds a patent for a nutritional supplement aimed at treating uremia. The patent describes mixtures of mixed salts formed between branched-chain alpha keto-acids and basic L-amino acids. These compositions are designed to be used in conjunction with a 20-30 g/day mixed quality protein diet and a vitamin and mineral supplement. Notably, his formulation contains fewer component salts than other salt mixtures with similar proportions of basic amino acids and keto acids.

Career Highlights

Throughout his career, Henri Bermudez has worked with prestigious institutions, including The Johns Hopkins University and Synthelabo. His work has focused on developing effective nutritional solutions for individuals suffering from chronic renal failure.

Collaborations

Henri has collaborated with notable professionals in his field, including Mackenzie Walser and Claude Bordat. Their combined expertise has contributed to the advancement of nutritional treatments.

Conclusion

Henri Bermudez's innovative work in nutritional supplements highlights his commitment to improving health outcomes for patients with uremia. His patent and collaborations reflect a dedication to scientific advancement in the field of nutrition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…